Authors: Karina A. Alenina; Dolores S. Bengoa; Yuliya Vlasova
Addresses: Higher School of Economics, National Research University, 38 Studencheskaya St. 38, Perm, 614070, Russia ' International Business Department, University of Applied Management Studies, Neckarauer street, 200, Mannheim 68173, Germany ' Higher School of Economics, National Research University, 38 Studencheskaya St. 38, Perm, 614070, Russia
Abstract: Global challenges, such as the high speed of the business internationalisation process, strong competition, natural environment or economic powers, are setting high standards for the pharmaceutical sector. For achieving this competitive sustainability, companies have to provide the best of their human capital and technological resources to reach great innovation levels. The paper explores reasons and motives that positively influence the innovative capacity and the potential for innovation in the Russian pharmaceutical market. The case study targeted a population of 100 subjects. Stratified and simple random sampling techniques are used to select a sample size of 50 respondents using questionnaires for data collection. Data are analysed through descriptive statistics and presented in frequency tables, graphs and computed percentages. The researchers recommend that management should minimise employee turnover to increase the skills of the employees, hiring staff should be done based on academic qualifications, and monetary and non-monetary resources should be allocated evenly for innovation purposes.
Keywords: innovative capacity; high tech firms; high technology; pharmaceutical industry; innovation potential; Russia; sustainable innovation; employee turnover; employee skills; academic qualifications; monetary resources; non-monetary resources.
Journal for Global Business Advancement, 2016 Vol.9 No.2, pp.146 - 166
Received: 08 May 2021
Accepted: 12 May 2021
Published online: 25 Mar 2016 *